Big Pharma At The Senate: When It Comes To Yes Or No Questions, There Are Still A Few Maybes

Our question-by-question infographic shows how Rx executives exhibited enough finesse to avoid any embarrassing sound bites at the Senate Finance Committee hearing on drug pricing.

YES and NO acceptance and rejection symbols vector for vote, election choice. Brush painted symbolic approval icons in square frames. Tick and cross signs, check marks graphic design. - Vector

The seven big pharma leaders who testified at the Senate Finance Committee hearing on drug pricing Feb. 26 largely stuck together in responding to questions, a united front that particularly stands out when looking at the executives' responses to the yes-or-no questions posed by senators.

Those types of questions could have presented a potential pitfall: a video clip of all seven admitting that yes, drug...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access